AI Eye Exams Gain Traction for Convenient Diabetic Retinopathy Screening
-
AI eye exam systems are being adopted to screen for diabetic retinopathy, providing fast, convenient diagnoses without needing a doctor present.
-
The technology has benefits for both patients (saving time/travel) and providers (increasing screening compliance).
-
3 companies have FDA clearance - the first fully autonomous AI diagnostic tools approved.
-
Reimbursement and integration into provider systems have been challenges, but adoption is growing.
-
The AI aims to expand access and early detection, helping prevent blindness through increased screening rates.